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Abstract
Magnetic drug targeting has been proposed as a means of efficiently targeting drugs to tumors. 
However, the extracellular matrix (ECM) remains a significant barrier to long-range 
magnetophoretic transport through the tumor volume. While ensemble measurements of 
nanoparticle magnetophoresis have been reported, a single particle level understanding of 
magnetophoretic transport remains at large. We quantify nanorod magnetophoresis through ECM 
based on single particle observations. We find that smaller diameter particles achieve larger 
velocities through ECM despite experiencing smaller magnetic forces. Additionally, two 
interesting dynamics are elucidated. First, 18 nm diameter nanorods experience bimodal stick-slip 
motion through ECM during static field magnetophoresis, while similar bimodal transport is not 
observed for 55 nm nor 200 nm diameter nanorods. Second, smaller particles experience larger 
deviations in their orientation angle with respect to the magnetic field. This work elucidates 
important dynamics of nanoparticle transport through complex, porous biomaterials that may go 
unnoticed during ensemble measurements.
1. Introduction
Nanoparticle (NP) delivery to solid tumors involves a series of mass transport processes 
through complexly structured biopolymer networks. Many of these biomaterials serve to 
inhibit effective, long-range distribution of NPs throughout the tumor volume. As such, one 
goal of the emerging field of transport oncophysics is to improve our understanding of the 
various mass transport processes involved in effective drug delivery to and within tumors1,2. 
Several review articles discuss the difficulties of intratumoral drug delivery3–6. While many 
studies have been performed quantifying magnetic particle transport through synthetic7–11 
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and biological12–15 polymer systems, fundamental questions about the dynamics of 
nanoparticle transport through biopolymer systems remain unanswered16. How do particles 
move in the complex environments of tissues? When pulled by a static magnetic gradient, do 
they experience constant velocity motion? A better understanding of how nanoparticles 
move during magnetic guidance through biological materials is critical for predicting how 
they will behave when implemented in vivo16.
From the blood stream there are three specific barriers which a NP-based therapeutic must 
traverse before reaching the interior of a tumor cell. After being administered, the NP must 
first cross the blood vessel wall to move from the blood stream into the tumor cell 
environment. Interestingly, angiogenesis results in tumor blood vessels which are 
comparatively leaky, with pores ranging from hundreds of nanometers to a few microns in 
diameter17. This is large compared with healthy blood vessels, which typically have pores 
only tens of nanometers in diameter. Following transport through the blood vessel wall, NPs 
must transit through the densely woven mesh of the extracellular matrix. The third physical 
barrier is, generally, the cell membrane. Each of these barriers pose specific difficulties for 
particles, as each biopolymer material has its own protein constituents and structure, from 
which follows its membrane function. Each inhibitory barrier has its own exclusionary 
guidelines with respect to nanoparticle size and surface chemistry (although generally, 
particles with very little surface charge pass most efficiently through these protein-rich 
environments18–20).
Magnetic nanoparticles (MNPs) have been implemented in drug and gene delivery21,22 for 
tumors23 as well as tissue generation24. Specifically, magnetic drug targeting (MDT) seeks 
to magnetically capture drug-loaded nanoparticles at a specified tumor location, continually 
applying magnetic fields at the disease site so as to guide NPs to, and increase NP 
accumulation at, the relevant site, thereby increasing the local concentration of drug payload 
and minimizing the systemic drug dose25. Measuring magnetically induced nanoparticle 
transport through various materials informs our understanding of the transport dynamics at 
work and several studies have provided useful data quantifying ensemble transport of 
magnetic nanoparticles through various synthetic and biological polymer systems7,9–14. 
Ensemble measurements have elucidated transport kinetics of particles en masse, however 
our understanding of how individual particles translate through the complex protein 
meshwork of the ECM during magnetophoresis is incomplete. Cribb et al. performed 
quantitative assessments of single particle magnetphoretic transport through solutions of 
entangled DNA15 and observed constant velocity motion for magnetic beads and rods 
moving through viscoelastic, partially entangled DNA solutions. However, DNA solutions 
are notably different from the extracellular matrix in fiber type, fiber dimensions, fiber 
connectivity, pore dimensions, and matrix homogeneity.
The ECM is composed primarily of collagen, laminin, and glycosaminoglycans (GAGs), 
each contributing to the physical and chemical complexity of the matrix and the difficulty 
nanoparticles experience in traveling through the material. Collagen and laminin are fiber-
forming proteins and compose the structural meshwork of the ECM26–28. GAGs are 
typically attached to the collagen-laminin latticework of the matrix29. Transport through the 
ECM is further complicated by the fact that these components organize themselves into a 
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matrix that typically has pores ranging from 25 nm to 2 μm in diameter, as demonstrated by 
the SEM micrographs of Matrigel shown in Fig. 1.
Pore size polydispersity is a crucial component in gaining a complete and accurate 
understanding of MNP transport through the ECM. This matrix feature is not well-replicated 
by gels of synthetic polymers because (1) synthetic polymer gels typically do not contain the 
multidimensional fiber-like structures exhibited by collagen and laminin, and (2) synthetic 
polymer gels tend to organize more homogenously and have lower pore size polydispersity. 
Indeed, it has been suggested that large pore size heterogeneity combined with the inherent 
and significant biological polymer stiffness found in mucus gels play a role in supressing 
particle transport through mucus; Kirch et al. discovered that particle magnetophoresis was 
inhibited more by mucus than by hydoxyethylcellulose gels, despite these gels having higher 
viscosities and smaller pore dimensions30.
In addition to having a highly heterogeneous pore size, the ECM also functions as a charge-
selective filter, effectively trapping particles carrying significant surface charges19,31. Thus, 
researchers seeking to achieve long-range nanoparticle transport through the tumor ECM 
typically implement a surface coating of polyethyleneglycol in order to mitigate surface 
charges on uncoated NPs. The need to mediate surface charge interactions between particles 
and their surrounding biopolymer matrix is another requirement which differentiates 
transport experiments performed in synthetic and biological polymer matrices.
2. Experimental Methods
We use template-guided electrodeposition to grow nickel nanorods in a custom 
electrodeposition cell. Standard three electrode deposition with a Pt auxiliary electrode, a 
Ag/AgCl double barrel reference electrode, and the thermally evaporated (Ag) template 
backing operating as the working electrode. Deposition is performed into the pores of 
Whatman Anodisc 13 anodized aluminum oxide (AAO) templates (200 nm diameter rods) 
or Synkera Inc. AAO templates (18 and 55 nm diameter rods). Following deposition we etch 
the Ag working electrode in 50% v/v nitric acid, then release the Ni nanorods by etching the 
AAO template in 0.5 M sodium hydroxide. Fabrication methods have been thoroughly 
documented in the literature32–34.
Proteins readily adsorb onto metal and metal oxide surfaces. Consequently, the particle 
surface plays a significant role in determining a particle's ability to avoid motion-inhibiting 
interactions with the matrix and move through a dense network of biopolymers18,35–37. 
Overall particle behaviour in a protein network is therefore a consequence of composite 
factors, including steric, hydrodynamic, and chemical interactions. While particles may be 
small enough to move through the pores of a given protein mesh based exclusively on size, 
chemical interactions between the mesh proteins and the particle surface can induce non-
specific binding, rendering the particle immobile. The metal oxide surfaces of the nanorods 
are natively covered with a hydroxyl layer. We modify the surfaces of all nanorods used in 
these experiments with methoxy-PEG-silane (1 kDa) according to the method demonstrated 
by Zhang et al.38, minimizing the zeta potential of all particles used in magnetophoresis 
experiments.
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Following PEGylation, we concentrate nanorods and chill solutions to 4 °C. We then cold-
pipette 1% v/v nanorod solution into Matrigel (chilled to 4 °C) and gently mix. Matrigel is 
an extracellular matrix composed primarily of collagen IV, laminin, and heparan sulfate 
proteoglycans isolated from the Engelbreth-Holm-Swarm (EHS) murine sarcoma. It is an 
accessible, purified, and readily available material for ECM-specific transport studies39. For 
these experiments, we store Matrigel at -30 °C until ready for use, then thaw it at 4 °C prior 
to mixing with nanorods. We store all pipettes, glass slides, and cover slips at 4 °C until use. 
After combining nanorods and Matrigel, we deposit a 7.5 μl volume onto a #0 glass cover 
slip, sealing the volume with a 120 μm thick polymer spacer (product #654008, Grace Bio-
Labs) and another cover slip. Following sealing we incubate the sample at 37 °C for 1 hour 
in a humidity controlled incubator.
After incubation we place the sample on a microscope for brightfield transmitted light 
microscopy using a 100x dry objective (Fig. 2a). We use a Pulnix PTM-6710CL camera and 
custom software to collect video at 1 frame per second for tens of minutes; we use Video 
Spot Tracker software40 (cismm.org) for tracking particles.
Magnetophoresis is performed in the static magnetic field of a calibrated cylindrical NdFeB 
permanent magnet (K&J Magnetics). The magnet and sample are aligned using a custom 3D 
printed polymer sample holder designed to center the focal plane of the sample with the 
center of the permanent magnet (Fig 2b). We calibrate the magnetic field using an F.W. Bell 
magnetometer at 250 μm increments, from 18 mm to 80 mm away from the magnet face 
(Fig. 2c).
3. Results and Discussion
We prepare nickel nanorods of varying diameters using the method of template guided 
electrodeposition34. Scanning electron micrographs of as prepared rods are shown in Fig. 
3a–c. We functionalize all nanorod surfaces with 1 kDa polyethylene glycol. Zeta potential 
measurements indicate that uncoated particles have an average zeta potential of -46 mV, 
while PEGylated nanorods have an average of -3 mV (Fig. 3d). TEM images confirm this 
surface coating, showing the highly heterogeneous contrast and rough surface indicative of a 
native oxide and the more uniform contrast of the polymer coating (Fig. 3e and 3f). In 
assessing nanorod size and magnetophoretic force we use the as prepared diameters of the 
rods.
Using transmitted light microscopy, we observe and quantify single particle transport 
through Matrigel in vitro for various nanorod sizes. While nanorod diameters are below the 
diffraction limit, rod lengths are not. The lengths of the rods makes visualization possible 
without the need for fluorescence labeling or localization via plasmonic response41. For 
magnetophoretic transport through a homogenous Newtonian fluid the relevant forces acting 
on the magnetic particle are composed exclusively of the magnetic force applied by the 
permanent magnet and drag force of the surrounding fluid. Single particle magnetophoresis 
through water has been previously demonstrated for quantifying particle magnetic 
properties42 and demonstrating the role diffusion plays in transport for a variety of 
nanovectors43. Experiments in Newtonian liquids make use of the equivalency Fdrag = 
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Fmagnet = -βην, where β is the particle geometry coefficient, η is the solution viscosity, and ν 
is the particle velocity. As such, experiments in Newtonian solution can obtain Fmagnet based 
on particle velocity, solution viscosity, and particle shape and size. In a gel network 
composed of connected fibrous proteins, the particles experience the additional steric force 
(Fsteric) imposed by the matrix fibers. Due to the immobile meshwork structure of the ECM, 
the sizes of the protein bundles involved, the sizes of the nanorods being pulled, and the 
innate heterogeneity of pores in the ECM, the requirements for implementing Stokes Law 
are not met. Thus, it cannot be used to fully describe nanorod magnetophoresis through the 
ECM. Later we will validate this via direct observation of particles experiencing large, 
inhibitory steric forces.
Because these experiments involve complex fibrous polymer systems, we take an analytical 
approach to calculating the magnetic force Fmagnet, using the magnetic properties of the 
nanorods and the applied field and field gradient to determine Fmagnet. We then use Fmagnet 
and the observed nanorod velocities to assess the apparent viscosity ηapparent that is 
experienced by a nanorod in ECM. This apparent viscosity is a composite of both the drag 
force Fdrag imposed by the liquid phase of the ECM, and the steric force Fsteric imposed by 
the matrix. Importantly, because steric forces play a major role in inhibiting particle motion, 
the apparent viscosity ηapparent is expected to depend strongly, and nonlinearly, on particle 
diameter.
From previous work15, the magnetic force applied to a prolate ellipsoid can be calculated 
based on particle volume (Vc for a prolate ellipsoid), permeability (μ0 for free space, μr for 
the material of interest), and the magnetic field and field gradient present (B and ∇B). For 
our cylindrical nickel nanorods we use a prolate spheroid approximation, yielding Fmagnet = 
[(ur – 1)/2μ0]·Vc·B∇B where Vc is the cylinder's volume44. Based on this relationship we 
calculate the forces on a nanorod of a given dimension. At the center of the, magnet (along 
the magnet axis) the field of a cylindrical magnet Bm(z) is
where μ0 is the permeability of free space, M0 is the magnetic saturation of the magnet, Lm is 
one half the length of the magnet, Rm is the magnet radius, and z is the distance from the 
magnet center15. This relation is confirmed by our magnetic field measurements (Fig. 2c) 
and is useful in calculating the field and field gradient experienced by the nanorod: by 
analytically calculating the force on a rod of known dimensions we compare how this force 
scales with rod length for a given rod radius and can do so without using hydrodynamic drag 
equations to calculate the applied force. From this we obtain the force on the particle given 
any surrounding material environment. Additionally, we can compare these force 
expectations with experimental results for how the application of force on variously sized 
rods impacts nanorod transport. This relationship is confirmed by our field measurements 
(Fig. 2c).
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Using the known rod diameters and measuring the lengths of individual rods undergoing 
magnetophoresis, we calculate nanorod volume and expected Fmagnet. We plot these 
calculated magnetic force values with average rod velocities for several rods (Fig. 4a). 
Because all nanorods have a similar range of lengths, the nanorod force is primarily 
attributed to variations in rod diameters. Velocity versus force data (Fig. 4a) clearly 
demonstrates the pore-size effect: smaller rods experiencing significantly less force move 
with significantly higher average velocities through the matrix. This demonstrates the 
limitations of using a purely Stokes-based drag force analysis of magnetophoresis through 
the extracellular matrix, which would predict larger velocities for larger particles 
experiencing larger forces. Previous magnetophoresis experiments performed on variously 
sized nanoparticles demonstrated differences in transport efficiency, noting that 
agglomerates of smaller particles moved more efficiently through ECM than agglomerates 
of large particles13. Our experiments build on these first demonstrations by applying single 
particle tracking for quantifying how force (particle size) impacts motion at the single 
particle level. Using this we directly observe the mechanisms by which smaller particles 
achieve enhanced motion through the ECM.
Apparent Viscosity
While taking a Stokes drag approach to calculating the force on a nanorod in Matrigel is 
innacurate macroscopically, it can be useful for describing the average, apparent, local 
nanorod microenvironment. Each nanorod's gradient driven motion can be converted to an 
apparent viscosity using the incorrect assumption that Matrigel is a Newtonian solution, 
allowing us to compare apparent viscosities felt by rods of various diameters. We find that 
55 nm and 200 nm diameter rods experience ηapparent values approximately two and four 
orders of magnitude larger than the ηapparent experienced by 18 nm rods, respectively (Fig. 
4b). Apparent viscosity calculations on nanorods moving through Newtonian solutions will 
all yield the same apparent viscosity. Thus, we can attribute these variations in apparent 
viscosity entirely to diameter-dependent differences due to steric hindrance experienced by 
the nanorods as they move.
Orientation angle
In magnetophoresis through a Newtonian fluid, motion analysis is based on the Stokes-
Einstein equation, Fmagnetic=βην, where β is the shape factor, η the viscosity, and ν the 
particle velocity. Increased velocity can only be achieved by either (1) increasing the applied 
Fmagnet, or (2) decreasing the medium viscosity. Indeed, it was previously suggested that 
applying AC magnetic fields (50 and 100 Hz) to particles during magnetophoresis induces 
local decreases in viscosity, thus enhancing particle transport velocities11. Because steric 
hindrance Fsteric plays a major role in transport inhibition for magnetophoresis through 
Matrigel, methods which operate to diminish the impacts of steric barriers, or avoid them 
altogether, will increase particle velocity. Translational diffusion is one such method of 
mediating the transport-diminishing impacts of steric barriers. Because translational 
diffusion allows a nanorod to tilt and thereby slide past a barrier in the ECM meshwork, it 
enhances a nanorod's chance of being pulled around a barrier by an applied field gradient. 
Narrow diameter nanorods not only have larger inherent translational diffusion coefficients, 
they also experience a smaller aligning force due to the applied magnetic field. To 
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demonstrate variations in the translational diffusion coefficients of the nanorods in Matrigel 
we collect data on the orientation angle of various rods during their transit through the 
matrix. Fig. 5 shows this data in histogram form, demonstrating angular excursions away 
from the applied field angle are ±4, ±8, and ±22 degrees for 200, 55, 18 nm diameter 
nanorods, respectively. Thus, we propose that the translational diffusion force on narrow 
nanorods under a static magnetic force is one method serving to enhance transport. We 
suggest that the larger angular diffusion coefficients of small diameter nanorods allow these 
particles to occasionally evade steric barriers which permanently encumber larger diameter 
nanorods. This ability to bypass steric barriers and move through pores in the matrix is 
critical for small rods undergoing magnetophoresis. This observation suggests that active 
methods for increasing translational diffusion of nanorods may increase translational 
velocities in complex matrices. However, it is important to note that this feature cannot be 
conveyed to rods of any size. Clearly rods must have one dimension (specifically, the 
dimension at the translational front of the nanoparticle) sufficiently below the matrix mesh 
size for this translational mechanism to be relevant. This data is unique in the field of 
magnetophoresis, as most experiments are performed on spherical particles and do not 
include single particle tracking data.
Constant versus varying velocity motion
We demonstrate, for the first time, varying velocity motion for nanoparticles undergoing 
magnetophoresis in a biologically relevant polymer gel. The difficulties in traversing 
biological barriers such as the ECM have motivated various innovations aimed at enhancing 
nanoparticle transport, including attaching collagenase to particle surfaces14, engineering 
particle shape45, and applying AC magnetic fields11. Varying velocity motion, as 
demonstrated by the particle track shown in Fig. 6, points to increasing transport efficacy by 
a method of applying force which may not come to mind by only observing constant 
velocity motion or particle transport en masse. Small diameter nanorods experience large 
path deviations normal to the direction of the field gradient. The smaller diameter particles, 
being less magnetically confined, also exhibit significantly larger variation in orientation 
angle with respect to the magnetic field. Considering that this angular variation may aide the 
narrow particles in evading steric hindrances, the notion of applying either (1) forces normal 
to the intended direction of translation, or (2) torsional forces centered around the long axis 
of the nanorod, may assist in releasing nanoparticles from their local steric hindrances. 
Indeed, future experiments invoking single particle tracking may look to study how particle 
transport is impacted by applying transverse or torsional magnetic forces. The experiments 
performed by MacDonald et al. demonstrate that transport efficiency through a homogenous 
synthetic gel is significantly enhanced (30-fold enhancement was observed) by the 
application of a transverse AC field, and the reasoning used invokes changes in the local 
viscosity of the gel due to the oscillating motion of the particles. In a homogenous gel this 
serves as an excellent explanation of how AC fields applied transverse to the intended 
direction of motion may induce more rapid transport. Single particle tracking of 
magnetophoresis experiments on nanorods in homogenous synthetic gels and inhomogenous 
biological gels may inform the field as to how AC fields operate to enhance transport 
through highly heterogeneous biomaterials. These findings suggest that, in designing a 
magnetic drug delivery system based on nanorods, applying forces normal to the intended 
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direction of nanorod motion may aid in long range nanorod translation. The acceleration-
deceleration motion observed for small rods may also suggest that balancing force 
application and free diffusion may lead to faster translational velocities, as durations of free 
diffusion may ensure that a particle is not being continually pulled into a mesh of tissue too 
dense to effectively move through.
Drug delivery figures of merit
While quantification of nanoparticle magnetophoresis at the single particle level informs our 
understanding of transport dynamics through complex biological environments, its medical 
relevance is only fully realized by applying figures of merit that indicate if the variations in 
average velocity will actually result in more efficient delivery of pharmaceutical payloads. 
Currently nanoparticle drug carriers transport their cargo by either volume loading (the drug 
is encapsulated within the volume of the particle) or surface loading (the drug is attached to 
the surface of the particle). Normalizing average velocities per particle by the specific 
particle's volume or surface area creates two figures of merit to address each type of cargo 
carrying method. Fig. 7 demonstrates these two figures of merit. Performing this simple 
normalization indicates that, in our experiments, 18 nm rods are slightly less efficient at 
moving payloads via volume loading (7a), and approximately equivalently efficient at 
moving payloads via surface loading (7b). Using these and similar figures of merit will be 
important in optimizing future particles with respect to size, shape, and transport velocities 
in biological materials. This result highlights the notion that magnetophoretic velocity is 
only one component of a particle's overall usefulness in delivering therapeutic payloads, and 
should be incorporated into figure of merit calculations with take into account an overall 
efficacy of delivery.
Conclusions
These experiments are the first demonstrations of single particle magnetophoresis through 
polymer matrices. They offer insight as to how varying particle sizes and forces impact 
particle transport through complex biological matrices at the single particle level. It has been 
long accepted that size and shape matter in drug delivery for processes such as EPR 
retention, circulation time46, passage through the blood brain barrier, diffusion through 
ECM47, and myriad other processes48. Here we demonstrate how magnetophoresis through 
the ECM varies for particles of different sizes. In addition to demonstrating fits-and-starts 
styled motion, we propose the notion of angular diffusion playing a significant role in 
allowing narrow nanorods to escape from protein dense ECM regions which provide large 
steric force hindrance. This notion raises the question of whether too much force may 
actually serve to diminish transport velocities by significantly suppressing angular diffusion.
The experiments described herein open up new understandings on magnetophoretic motion 
of particles through complex networks of biopolymers. We observe significantly varying 
velocities, and functionally different modes of translation, for nanorods of varying 
diameters. However, despite these large variations in velocity, we observe surprisingly small 
differences in the figures of merit that quantify payload delivery. Our quantification of how 
individual particle velocities translate to volume or surface loaded payload delivery may 
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provide useful information for the future design of particles designed to translate long 
distances (hundreds of micrometers or more) through biopolymers. While we have used 
Matrigel to test nanoparticle transport, the parameter space for testing is large. Drug delivery 
through mucus, serum, and biomembranes could all be studied in a similar manner.
Additionally, our experiments probe a small fraction of the particle shape parameter space. 
Researchers have shown that particle shape plays an important role in how biological 
entities interface with micro- and nanoscale particles46,49. New techniques have been 
developed for imparting exquisite control over particle shape50,51.
Future experiments exploring how exotically shaped particles move through biopolymers 
may elucidate shape-dependent transport mechanisms which engineers and pharmaceutical 
scientists can exploit to create more effective drug delivery vehicles.
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Scanning electron micrographs of prepared Matrigel.
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(a) Experimental setup. (b) Custom 3D printed microscope stage attachment for calibrated 
magnetophoresis experiments. (c) Experimental measurements of magnetic field (red 
circles) as a function of distance from the face of the magnet (measurements collected at 
0.25 mm increments ). The theoretical field and distance relationship based on Eq. 1 is 
shown (black line).
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Scanning electron micrographs of nickel nanorods with nominal diameters of (a) 200 nm, 
(b) 55 nm, and (c) 18 nm. Scale bars in (a) – (c) are 1 μm. Zeta potential measurements of 
rods reveal drastic differences before and after PEGylation (d). TEM images reveal the 
rough native oxide surface (e) and the smooth, functionalized PEG surface (f).
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(a) demonstrates the discrepancy between Fmagnet and velocity. Interestingly, data points for 
18 nm diameter rods show relatively large variation in average velocity. Video analysis 
clearly indicates that long residence times exist for 18 nm diameter nanorods. The variation 
in velocity for both 55 nm and 200 nm rods is considerably smaller because of their 
unanimous steric hindrance: due to their larger diameters, all 55 nm and 200 nm diameter 
rods experienced significant steric hindrance at all times (as opposed to intermittent steric 
hindrance experienced by 18 nm diameter rods). (b) Treating Matrigel as a Newtonian 
material, the nanorod velocity as a function of diameter can be used to understand the 
particle's viscosity perspective as it travels, averaged over long travel times (minutes). Force 
distributions are considerably larger for 200 nm diameter rods due to significantly larger 
variation in nanorod lengths.
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Nanorod orientation angles with respect to the magnetic field direction. Larger rods 
experience smaller translational diffusion. 200 nm, 55 nm, and 18 nm diameter rods 
experience maximum orientation angle deviations of ±4, ±8, and ±22 degrees, respectively.
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Acceleration-deceleration motion observed for 18 nm diameter nanorods during 
magnetophoresis. (a) Minimum intensity projections of nanorods moving through ECM (1 
frame per second) can be tracked (b) and demonstrates locations of significant steric 
hindrance (c, arrows). Particle motion, and direction of increasing magnetic gradient, is in 
the +x direction. Significant motion in the +/-y directions, as well as motion in the –x 
direction, elucidates the complexity of magnetophoretic transport for small diameter 
nanorods in dense polymer networks.
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Figures of merit based on (a) volume and (b) surface area loading of a relevant drug or 
therapeutic molecule. Normalizing particle velocity through multiplying velocity by volume 
or surface area provides a more applicable understanding of how particle size and velocity 
through ECM should be assessed for delivering molecules efficiently.
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